• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经肌肉阻滞药物阿曲库铵与毒蕈碱型乙酰胆碱受体的相互作用。

Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.

作者信息

Musílková J, Starshinova L A, Shelkovnikov S A, Tucek S

机构信息

Institute of Physiology, Czechoslovak Academy of Sciences, Prague.

出版信息

Physiol Res. 1991;40(3):293-304.

PMID:1751476
Abstract

On isolated rat heart atria, atracurium competitively antagonized the negative chronotropic effect of methylfurmethide, shifting the concentration-response curve to the right without diminishing the agonist's maximal effect; Kd calculated from dose ratios was 3.0 mumol/l. On the longitudinal muscle of rat ileum, atracurium antagonized the effect of methylfurmethide in a non-competitive manner; at 50 mumol/l atracurium, the maximum response to methylfurmethide was diminished by about 50%. Atracurium antagonized the binding of (3H)quinuclidinyl benzilate [3H)QNB) to muscarinic binding sites in the atria, ileal longitudinal muscle and cerebellum with IC50 values of 5-8 mumol/l, and in brain cortex of 25 mumol/l. Atracurium was little efficient, however, in antagonizing the binding of N-(3H-methyl) scopolamine [3H)NMS) to muscarinic binding sites. Complete blockade was not achieved at concentrations up to 1 mmol/l. Concentrations required to diminish the binding by 50% were 10 - 1000 times higher for (3H)NMS than for (3H)QNB. Atracurium brought about the dissociation of (3H)QNB-receptor complexes, but its effect was considerably stronger at a concentration of 30 mumol/l than at 1 mmol/l. Atracurium slowed down the dissociation of (3H)QNB-receptor complexes observed after the addition of atropine. The effects of atracurium on the dissociation of (3H)NMS-receptor complexes were similar to those on (3H)QNB-receptor complexes, but a high concentration of atracurium (1 mmol/l) produced a transient increase in (3H)NMS binding preceding its subsequent dissociation. Although the observations of the antagonism by atracurium of the effect of methylfurmethide on the heart atria, and of the inhibition of the specific binding of (3H)QNB to the atria, ileal smooth muscle, cerebellum and brain cortex are compatible with the assumption of a competitive interaction, the discrepancy between the effects of atracurium on the binding of (3H)QNB and (3H)NMS indicates that atracurium does not bind to the same binding site as (3H)QNB and (3H)NMS. It appears that most effects of atracurium on muscarinic receptors are allosteric and that both negative and positive cooperatives play a role in interactions between atracurium and muscarinic ligands.

摘要

在离体大鼠心房肌上,阿曲库铵竞争性拮抗甲呋烟腙的负性变时作用,使浓度 - 效应曲线右移,而不降低激动剂的最大效应;根据剂量比计算的Kd为3.0 μmol/L。在大鼠回肠纵行肌上,阿曲库铵以非竞争性方式拮抗甲呋烟腙的作用;在阿曲库铵浓度为50 μmol/L时,甲呋烟腙的最大反应降低约50%。阿曲库铵拮抗(3H)喹核醇基苯甲酸酯[(3H)QNB]与心房肌、回肠纵行肌和小脑毒蕈碱结合位点的结合,IC50值为5 - 8 μmol/L,在大脑皮质中为25 μmol/L。然而,阿曲库铵拮抗N - (3H - 甲基)东莨菪碱[(3H)NMS]与毒蕈碱结合位点结合的效率很低。在浓度高达1 mmol/L时未实现完全阻断。使(3H)NMS结合减少50%所需的浓度比(3H)QNB高10 - 1000倍。阿曲库铵导致(3H)QNB - 受体复合物解离,但其在30 μmol/L浓度时的作用比在1 mmol/L时强得多。阿曲库铵减慢了加入阿托品后观察到的(3H)QNB - 受体复合物的解离。阿曲库铵对(3H)NMS - 受体复合物解离的作用与对(3H)QNB - 受体复合物的作用相似,但高浓度的阿曲库铵(1 mmol/L)在其随后解离之前使(3H)NMS结合出现短暂增加。尽管观察到阿曲库铵拮抗甲呋烟腙对心房肌作用以及抑制(3H)QNB与心房肌、回肠平滑肌、小脑和大脑皮质特异性结合的现象与竞争性相互作用的假设相符,但阿曲库铵对(3H)QNB和(3H)NMS结合作用的差异表明,阿曲库铵与(3H)QNB和(3H)NMS并非结合于同一结合位点。看来阿曲库铵对毒蕈碱受体的大多数作用是别构性的,并且负性和正性协同作用在阿曲库铵与毒蕈碱配体的相互作用中均起作用。

相似文献

1
Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.神经肌肉阻滞药物阿曲库铵与毒蕈碱型乙酰胆碱受体的相互作用。
Physiol Res. 1991;40(3):293-304.
2
Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.阿库氯铵和N-甲基东莨菪碱与毒蕈碱型乙酰胆碱受体结合中的正协同性。
Mol Pharmacol. 1990 Nov;38(5):674-80.
3
Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum.神经肌肉阻断药物阿库氯铵、十烃季铵、加拉明、泮库溴铵、瑞库溴铵、罗库溴铵和d -筒箭毒碱与心脏和回肠中毒蕈碱型乙酰胆碱受体的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 1985 Apr;329(2):176-81. doi: 10.1007/BF00501209.
4
Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs.
J Pharmacol Exp Ther. 1986 Jan;236(1):219-23.
5
Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.不可逆性和季铵类毒蕈碱拮抗剂可区分大鼠脑中多个毒蕈碱受体结合位点。
J Pharmacol Exp Ther. 1989 Mar;248(3):1116-22.
6
Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.配体选择对加拉明与心脏毒蕈碱受体表观结合谱的影响。加拉明与毒蕈碱受体相互作用的三种主要类型的鉴定。
J Pharmacol Exp Ther. 1988 Sep;246(3):829-38.
7
Characterization of cholinergic muscarinic receptors in the rabbit iris.
Biochem Pharmacol. 1988 Jul 1;37(13):2575-83. doi: 10.1016/0006-2952(88)90249-3.
8
Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.神经肌肉阻滞剂加拉明和泮库溴铵诱导的心肌毒蕈碱受体结合位点的异质性。
Mol Pharmacol. 1983 Jul;24(1):15-22.
9
[3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.[3H]三环哌酯与脑毒蕈碱型乙酰胆碱受体的结合:与[3H]喹核醇基苯甲酸酯的比较。
Pharmacol Res. 1996 Apr-May;33(4-5):283-9. doi: 10.1006/phrs.1996.0040.
10
[Analysis of muscarinic receptors on rat pancreatic acini by using 125I-quinuclidinyl benzilate and N-[3H]-methylscopolamine].
Nihon Shokakibyo Gakkai Zasshi. 1991 Aug;88(8):1571-8.